Levomecor Inc.
Clinical trials sponsored by Levomecor Inc., explained in plain language.
-
New hope for stubborn depression? Add-On drug trial seeks better relief
Disease control TerminatedThis study tested whether a new drug called REL-1017 could help people with major depression who were still struggling despite taking standard antidepressant medication. Participants continued their usual medication and were randomly assigned to also take either REL-1017 or a pla…
Phase: PHASE3 • Sponsor: Levomecor Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New hope for Tough-to-Treat depression? trial tests Add-On pill
Disease control TerminatedThis study tested whether a daily pill called REL-1017 could help people with major depression who weren't getting enough relief from their current antidepressant. Participants took either the new pill or a placebo (sugar pill) for four weeks while continuing their regular medica…
Phase: PHASE3 • Sponsor: Levomecor Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC